-
Sacubitril/valsartan, sold
under the
brand name
Entresto among others, is a fixed-dose
combination medication for use in
heart failure. It
consists of...
-
Sacubitril (/səˈkjuːbɪtrɪl/; INN) is an
antihypertensive drug used in
combination with valsartan. The
combination drug
sacubitril/valsartan,
known during...
-
renal failure. As
shown in the PARADIGM-HF study,
valsartan combined with
sacubitril for the
treatment of
heart failure,
significantly reduced all
cause and...
- or
Arnisee ARNI,
angiotensin receptor-neprilysin inhibitor: Valsartan/
sacubitril Arani (disambiguation) Arny (disambiguation) This
disambiguation page...
-
heart failure.
Sacubitril/valsartan (Entresto/LCZ696),
which has been
tested against enalapril in
patients with
heart failure.
Sacubitril (AHU-377), a prodrug...
- (NEP). Recently, NEP
inhibitors have been developed, such as
Sacubitril and
Sacubitril/valsartan. They may be
clinically useful in
treating patients...
- (secukinumab)
Psoriasis Diovan (valsartan)
Hypertension 4,417 2012 −22%
Entresto (
sacubitril/valsartan)
Heart failure Enterovioform (clioquinol)
Amoebiasis Eucreas/Galvus...
-
Olmesartan medoxomil,
amlodipine and
hydrochlorothiazide C09DX04
Valsartan and
sacubitril C09DX05
Valsartan and
nebivolol C09DX06 Candesartan,
amlodipine and hydrochlorothiazide...
- (INN; or LBQ657) is the
active metabolite of the
antihypertensive drug
sacubitril,
which is used in the
treatment of
heart failure.
Solomon SD. "HFpEF in...
-
heart failure. The
angiotensin receptor-neprilysin
inhibitors (ARNI)
sacubitril/valsartan is
recommended as the
first choice of RAS
inhibitors in American...
